NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.

Rossignol P, Duarte K, Bresso E, A Å, Devignes MD, Eriksson N, Girerd N, Glerup R, Jardine AG, Holdaas H, Lamiral Z, Leroy C, Massy Z, März W, Krämer B, Wu PH, Schmieder R, Soveri I, Christensen JH, Svensson M, Zannad F, Fellström B

Open source

DOI: 10.1093/ehjopen/oeac069
Published: 2022 Nov
Container: European heart journal open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ehjopen/oeac069,
  title = {NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.},
  author = {Rossignol P and Duarte K and Bresso E and A Å and Devignes MD and Eriksson N and Girerd N and Glerup R and Jardine AG and Holdaas H and Lamiral Z and Leroy C and Massy Z and März W and Krämer B and Wu PH and Schmieder R and Soveri I and Christensen JH and Svensson M and Zannad F and Fellström B},
  year = {2022},
  journal = {European heart journal open},
  doi = {10.1093/ehjopen/oeac069},
  url = {https://doi.org/10.1093/ehjopen/oeac069}
}

RIS

TY  - JOUR
TI  - NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.
AU  - Rossignol P
AU  - Duarte K
AU  - Bresso E
AU  - A Å
AU  - Devignes MD
AU  - Eriksson N
AU  - Girerd N
AU  - Glerup R
AU  - Jardine AG
AU  - Holdaas H
AU  - Lamiral Z
AU  - Leroy C
AU  - Massy Z
AU  - März W
AU  - Krämer B
AU  - Wu PH
AU  - Schmieder R
AU  - Soveri I
AU  - Christensen JH
AU  - Svensson M
AU  - Zannad F
AU  - Fellström B
PY  - 2022
JO  - European heart journal open
DO  - 10.1093/ehjopen/oeac069
UR  - https://doi.org/10.1093/ehjopen/oeac069
ER  -

APA

P, R., K, D., E, B., Å, A., MD, D., N, E., N, G., R, G., AG, J., H, H., Z, L., C, L., Z, M., W, M., B, K., PH, W., R, S., I, S., JH, C., M, S., F, Z., & B, F. (2022). NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.. European heart journal open. https://doi.org/10.1093/ehjopen/oeac069

Source records

pubmed · retrieved 2026-09-27T14:38:01.143Z